Theravance Biopharma (TBPH) Earnings Date & Reports
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines... Show more
TBPH is expected to report earnings to rise 772.00% to 61 cents per share on March 02
Q4'25
Est.
$0.61
Q3'25
Beat
by $0.20
Q2'25
Beat
by $0.41
Q1'25
Missed
by $0.05
Q4'24
Missed
by $0.11
The last earnings report on November 10 showed earnings per share of 7 cents, beating the estimate of -12 cents. With 817.91K shares outstanding, the current market capitalization sits at 908.56M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TBPH showed earnings on November 10, 2025. You can read more about the earnings report here.